Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Was Onyx worth it? Amgen's case is looking up as Kyprolis bests Velcade in head-to-head trial
Was Onyx worth it? Amgen's case is looking up as Kyprolis bests Velcade in head-to-head trial
Was Onyx worth it? Amgen's case is looking up as Kyprolis bests Velcade in head-to-head trial
Submitted by
admin
on March 3, 2015 - 8:05am
Source:
Fierce Pharma
News Tags:
ONYX Pharmaceuticals
Amgen
Velcade
Kyprolis
Multiple Myeloma
Headline:
Was Onyx worth it? Amgen's case is looking up as Kyprolis bests Velcade in head-to-head trial
Do Not Allow Advertisers to Use My Personal information
